SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Discussion centers on a product shown at Foxconns Tech Day and POETs presence in Foxconns photonics ecosystem, which traders view as validation of the optical-engine partnership and a possible step toward commercialization. Bulls are anticipating orders and production updates, while skeptics stress that a demonstration is not proof of purchase orders or scaled shipments.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention ahead of topline survival results from its Phase 3 REGAL trial of GPS, after the trial reached its 80th-event milestone; traders are also watching SLS009 data expected at ASH. Many holders are buying or staying invested in anticipation of positive results, while skeptics point to the stocks sharp declines and warn that the trial outcome remains uncertain.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris strong Q3 results, led by rapid Recorlev growth, a higher full-year revenue outlook and a raised 2030 target, have driven a sharp rally and expectations of further analyst upgrades. Traders are broadly bullish on the growth trajectory, while takeover and bidding-war talk remains speculative and unconfirmed.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys engine, technology-licensing and engineering-support agreement with AST SpaceMobile for its planned heavy-lift rocket is driving attention, with traders viewing it as a major validation of Fireflys propulsion business and a boost to its backlog and funding outlook. Some remain cautious about the AST shares included in the deal, potential dilution, execution risks and the upcoming earnings report.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos sharp rebound is being tied to its Q3 update, including a reported earnings beat and an agreement to reserve manufacturing capacity for future reactor components. Traders are split between viewing the supply-chain and nuclear-development progress as a positive signal and arguing that the companys limited revenue, long commercialization timeline, and insider selling and dilution concerns make the bounce fragile.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs stronger-than-expected quarterly results and raised full-year revenue outlook are driving attention, with traders highlighting growth, backlog and momentum across quantum stocks. The reaction is broadly upbeat, though skeptics question cash burn, dilution and how much growth reflects acquisitions rather than the core quantum business.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

AMPX is drawing attention after a sharp rebound from a recent selloff, alongside call-heavy options activity and a broader rebound in electrical-equipment and data-center infrastructure stocks. Traders are split on whether the move marks a lasting recovery or a short-term bounce, with the upcoming earnings report also in focus.

Energy Transfer LP engages in natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities, and gathering systems and delivery of natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition, and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acquisition, and marketing services to crude oil markets. The Investment in Sunoco LP segment refers to the distribution of motor fuels to independent dealers, distributors, and other commercial customers and the distribution of motor fuels to end-user customers at retail sites. The Investment in USAC segment offers compression services to its customers in connection with infrastructure applications including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. The company was founded by Kelcy L. Warren in 1996 and is headquartered in Dallas, TX.

Energy Transfer LP - Unit

Energy Transfer LP Unit

ETs recent pullback has traders debating whether the weakness reflects the ex-distribution date and higher interest-rate pressure, or lingering concerns about a Williams-related lawsuit and whether strong NGL results can be repeated. Income-focused holders are treating the dip as a buying opportunity, while more cautious traders point to legal and earnings uncertainty.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Positioning ahead of Constellations upcoming earnings report is drawing attention, with traders weighing expectations for results and guidance against concerns that AI data-center power contracts may take years to translate into revenue. Bulls see lasting demand for nuclear power, while skeptics question whether delayed or scaled-back data-center construction could weaken the growth story.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

INFQs sharp rebound is drawing attention alongside a broader quantum-sector bounce, which traders link in part to Intels move into quantum. Some see renewed sector interest and possible short covering, while others view the move as an oversold bounce and are waiting for earnings or concrete commercial wins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Definitive Healthcare Corp. (DH) Tops Q3 Earnings and Revenue Estimates

Definitive Healthcare (DH) delivered earnings and revenue surprises of +50.00% and +0.19%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Definitive Healthcare (DH) Q2 2026 Earnings Call

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates

Definitive Healthcare (DH) delivered earnings and revenue surprises of +25.00% and -1.02%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Pinterest (PINS) Q2 Earnings and Revenues Beat Estimates

Pinterest (PINS) delivered earnings and revenue surprises of +19.44% and +2.39%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for

Definitive Healthcare (DH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Restaurant365 Names Kate Hastings Chief Customer Officer as It Expands Investment in Customer Success

Restaurant365 Names Kate Hastings Chief Customer Officer as It Expands Investment in Customer Success Restaurant365 Names Kate Hastings Chief Customer Officer as It Expands Investment in Customer Success PR Newswire IRVINE, Calif., June 23, 2026 Customer success leader joins executive team to help...

Can Definitive Healthcare Corp. (DH) Maintain Stability After Revised Price Target From Baird?

Can Definitive Healthcare Corp. (DH) Maintain Stability After Revised Price Target From Baird...

Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates

Definitive Healthcare (DH) delivered earnings and revenue surprises of +100.00% and -24.13%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Teradata (TDC) Tops Q1 Earnings and Revenue Estimates

Teradata (TDC) delivered earnings and revenue surprises of +14.29% and +4.13%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Docebo Inc. (DCBO) Reports Next Week: Wall Street Expects Earnings Growth

Docebo (DCBO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. Its solution offers information on healthcare providers and their activities to help the customers optimize from product development to go-to-market planning, sales, and marketing execution. The company was founded by Jason Kranzt in February 2011 and is headquartered in Framingham, MA.

Definitive Healthcare Corp - Ordinary Shares - Class A

Bearish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

DH Definitive Healthcare Corp - Ordinary Shares - Class A

Fundamentals

Latest DH News